Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Matzdorff

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Deutsches Arzteblatt International|March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous ThromboembolismJan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
Blood Advances|April 12, 2023
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITPJulia-Annabell Georgi, Jan Moritz Middeke, Martin Bornhäuser, et al.
Seminars in Hematology|May 14, 2013
Understanding the importance of using patient-reported outcome measures in patients with immune thrombocytopeniaMonika Kirsch, Robert J Klaassen, Sabina De Geest, et al.
Oncology Research and Treatment|April 13, 2018
Immunthrombozytopenie - aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH, GPOH und DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Oncology Research and Treatment|September 21, 2018
Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Expert Review of Hematology|November 30, 2020
Romiplostim in adults with newly diagnosed or persistent immune thrombocytopeniaMaria L Lozano, Bertrand Godeau, John Grainger, et al.
Oncology Research and Treatment|September 26, 2015
Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on HemostasisAxel Matzdorff, Hanno Riess, Frauke Bergmann, et al.
Onkologie|May 21, 2010
[Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH]Axel Matzdorff, Aristoteles Giagounidis, Andreas Greinacher, et al.
Hamostaseologie|July 15, 2024
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.)Stefani Parmentier, Steffen Koschmieder, Larissa Henze, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]Marcus M Mücke, Tony Bruns, Ali Canbay, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Deutsches Arzteblatt International|March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous ThromboembolismJan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
Blood Advances|April 12, 2023
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITPJulia-Annabell Georgi, Jan Moritz Middeke, Martin Bornhäuser, et al.
Seminars in Hematology|May 14, 2013
Understanding the importance of using patient-reported outcome measures in patients with immune thrombocytopeniaMonika Kirsch, Robert J Klaassen, Sabina De Geest, et al.
Oncology Research and Treatment|April 13, 2018
Immunthrombozytopenie - aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH, GPOH und DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Oncology Research and Treatment|September 21, 2018
Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Expert Review of Hematology|November 30, 2020
Romiplostim in adults with newly diagnosed or persistent immune thrombocytopeniaMaria L Lozano, Bertrand Godeau, John Grainger, et al.
Oncology Research and Treatment|September 26, 2015
Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on HemostasisAxel Matzdorff, Hanno Riess, Frauke Bergmann, et al.
Onkologie|May 21, 2010
[Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH]Axel Matzdorff, Aristoteles Giagounidis, Andreas Greinacher, et al.
Hamostaseologie|July 15, 2024
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.)Stefani Parmentier, Steffen Koschmieder, Larissa Henze, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]Marcus M Mücke, Tony Bruns, Ali Canbay, et al.
Pageof 5